Zentiva has announced the completion of its acquisition of 51% of Sicomed (a leading generics company in Romania) for USD 102m. Zentiva intends to launch a buyout offer for the remaining 49%. Based on the acquisition we have upgraded Zentiva to Buy with a target price of CZK 1,334 per share (23% upside) on September 21.